Par Health USA, LLC recalls Buprenorphine HCl
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Crystallization; identified as Buprenorphine free base
- Products
-
- Buprenorphine HCl
- Company
- Par Health USA, LLC
- Where it was sold
-
Nationwide in the USA.
Nationwide
- Units affected
- 46,334 units
- About this recall
- Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05